Clonal hematopoiesis of indeterminate potential risk score for predicting clinical outcome in patients with heart failure with preserved ejection fraction
Clicks: 2
ID: 323408
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.3
/100
2 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #234 of 282 articles by views in European heart journal supplements : journal of the European Society of Cardiology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 282 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Background Clonal hematopoiesis of indeterminate potential (CHIP) is prevalent among patients with heart failure with preserved ejection fraction (HFpEF) and has been linked to systemic inflammation. However, the plasma proteomic profiles associated with specific CHIP driver mutations and their prognostic relevance in HFpEF are not well characterized. Purpose To identify circulating protein signatures associated with CHIP driver mutations and to develop and externally validate a CHIP-related proteomic risk score (CHIP-ProtRS) for predicting adverse clinical outcomes in HFpEF. Methods The derivation cohort included 118 participants from TOPCAT. Associations between CHIP mutations and plasma protein levels were examined using gene-specific linear regression with adjustment for multiple testing. Proteins significantly associated with individual CHIP driver genes were used to construct gene-specific proteomic classifiers via nested cross-validated LASSO logistic regression. A composite CHIP-ProtRS was subsequently derived using LASSO Cox regression and externally validated in three independent HFpEF cohorts (n=654). The primary endpoint was a composite of death and heart failure hospitalization. Results Among TOPCAT participants, 30.5% carried at least one CHIP mutation. Distinct proteomic signatures were identified for TET2 (7 proteins), DNMT3A (9 proteins), and PPM1D (6 proteins), predominantly related to immune and inflammatory pathways. Gene-specific LASSO models demonstrated good discrimination for CHIP mutation status (AUC range 0.743–0.830). The CHIP-ProtRS was independently associated with the primary endpoint in the derivation cohort (adjusted HR 1.42, 95% CI 1.04–1.95) and in the external validation cohorts (HR 1.15, 95% CI 1.01–1.31) (Table 1). Risk stratification by CHIP-ProtRS tertiles was consistent across derivation and validation cohorts (log-rank p=0.034 and p=0.001, respectively) (Figure 1). Conclusion CHIP is associated with distinct alterations in circulating immune and inflammatory proteins in HFpEF. A proteomic risk score derived from these signatures is independently associated with adverse clinical outcomes, supporting the potential role of CHIP-ProtRS as a biomarker of risk and underlying disease biology in HFpEF.Table 1.Multivariable Cox analysis Figure 2.Cumulative incidence curves
| Reference Key |
openalex_W7172246551
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | M Kim, V Subramanian, A Pandey, J Chirinos, H Tavolinejad, M Sarmiento Bustamante, B Pourmussa |
| Journal | European heart journal supplements : journal of the European Society of Cardiology |
| Year | 2026 |
| DOI |
10.1093/eurheartjsupp/suag097.211
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.